Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach fr
| Image |  |
|---|---|
| Description | scientific article published on 12 February 2018 |
| Author/s |
author: Cristina Scarpazza Diego Centonze |
| Publication date | February 12, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |